Statistics

Total Visits

Views
Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain3

Select a period of time:

Number of views in the range

Views
Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain3

Views

Views
December 20230
January 20241
February 20240
March 20240
April 20240
May 20242
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Boardman1
Chicago1